
Bear wakes from hibernation 'happy and healthy' after pioneering brain op
Boki, a European brown bear, was suffering seizures and vision problems due to a build up of fluid putting pressure on his brain.
Vets feared if they didn't operate before he went into torpor (a winter dormancy similar to hibernation) he might not wake up again.
In October, he had a three-hour operation to run a tube run from his brain, under his skin and down to his bladder so the excess fluid could be drained.
The Edinburgh-based specialist in charge, Romain Pizzi, had only done it once before - on an Asiatic black bear in Laos.
Three-year-old Boki has now made a "remarkable recovery" and is off his medication with no adverse effects, according to the Kent-based Wildwood Trust.
His emergence from semi-hibernation is said to be a key step in his recovery.
"He's looking brilliant, happy and healthy and we haven't seen any negative signs from him. All his personality traits are still there - he's still the same old Boki that we love," said head of bears Jon Forde.
"Boki did well for his first ever winter sleep," he added.
"He lost around 30kg - we think a lot of this because he's actually grown while he was asleep so a lot of energy has been used for that."
The bear was rejected by his mother as a cub and moved to the trust, based near Canterbury, in December 2022.
Boki was being integrated with two adult bears, Fluff and Scruff, but had to be separated after the seizures started.
It's now hoped they can get reacquainted and become friends.
"While the signs are very positive, we still need to proceed with caution and to take care with the reintroduction to Fluff and Scruff," said head of zoo operations Mark Habben.
"This will involve boisterous play, which we want to minimise in these early stages post-torpor.
"We will monitor him very closely and, at some point over the coming months, we will conduct that introduction if everything continues to go well.
"We have to take this step for his wellbeing and theirs as well - they want to be together."
Boki's condition is called hydrocephalus and also occurs in humans, affecting one in every 500 births.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


BBC News
7 hours ago
- BBC News
What body odour reveals about your health
We emit a barrage of whiffy chemicals through our pores and in our breath. Some are a sign that we might be getting ill – and could be used to diagnose diseases up to years in advance. It was obviously nonsense. That was how analytical chemist Perdita Barran reacted when a colleague told her about a Scottish woman who claimed she could smell Parkinson's disease. "She's probably just smelling old people and recognising symptoms of Parkinson's and making some association," Barran remembers thinking. The woman, a 74-year-old retired nurse called Joy Milne, had approached Barran's colleague Tilo Kunath, a neuroscientist at the University Edinburgh, at an event he was speaking at in 2012. Milne told Kunath that she had first discovered her ability after noticing her husband, Les, had developed a new musky odour years earlier. He was later diagnosed with Parkinson's disease, a progressive neurodegenerative illness characterised by tremors and other motor symptoms. It was only when Milne attended a group meeting for Parkinson's patients in her home town of Perth, Scotland, that she made the connection: all the patients had the same musky smell. "So, we then decided to test whether she was right," says Barran, who worked at the University of Edinburgh at the time but is now at the University of Manchester.


BBC News
a day ago
- BBC News
Canterbury Christ Church University launches midwifery course
A Kent university is launching a new midwifery degree which aims to incorporate artificial intelligence and teaching about healthcare Christ Church University (CCCU) says its new course will "ensure that our students are well prepared to navigate the complexities of modern maternity care" when it starts in new course comes after the Nursing and Midwifery Council, which has approved it, withdrew accreditation for a previous CCCU midwifery course in Paul Driscoll-Evans, dean of the university's midwifery school, said it had "worked closely with health leaders across Kent, Medway and at national level" to design the course. "Our new curriculum is built on the principles of innovation, inclusivity, excellence and sustainability, ensuring that our students are well prepared to navigate the complexities of modern maternity care."In May 2023, the Nursing and Midwifery Council highlighted concerns that students were not gaining the expertise needed to deliver safe, effective and kind to the university, the new course will incorporate new technologies including AI and virtual healthcare to prepare prospective midwives for future advances in course will be delivered by the university with input from Kent healthcare services including NHS Kent and Medway, as well as maternity service on the course will also teach about how race, gender and other identities can affect people's experience of course will take on its first cohort of 25 students at the university's Canterbury Campus this year, with another cohort at its Medway campus launching in Fox-Collins, director for maternity, neonatal and women's health services at NHS Kent and Medway, said: "Giving people who are passionate about the midwifery profession the opportunity to undertake their training in the maternity services across Kent and Medway will enrich our workplaces and improve our services further."

Western Telegraph
a day ago
- Western Telegraph
Mounjaro prices double as weight loss jab popularity soars
US-based Eli Lilly says a 5mg dose will nearly double from £92 to £180 from September 1, while a 15mg pen will rise from £122 to £330. A Lilly spokesperson said: 'Following a review, Lilly will increase the UK list price for Mounjaro (tirzepatide) from 1 September to address pricing inconsistencies compared to other developed countries, including in Europe. We have reached an agreement with the NHS to ensure continued supply and patient access." The statement continues: 'While Lilly does not determine the prices that private healthcare providers set, we are working with them to maintain patient access. The UK was one of the first countries where Lilly launched Mounjaro, and our priority was to bring it to patients as quickly as possible during a time of limited supply of GLP-1 RA treatments for type 2 diabetes. 'At launch, Lilly agreed to a UK list price that is significantly below the European average to prevent delays in NHS availability." More than 1.5 million people in the UK are believed to be using weight-loss medication each month, with most buying the jabs from private pharmacies. Mounjaro users report surprising side effect - pharmacists share their tips — Bucks Free Press (@bucksfreepress) August 8, 2025 This comes as the Government has joined forces with Eli Lilly in a bid to tackle obesity. The move could see patients accessing care at pharmacies or by using online platforms. The £85 million programme from Eli Lilly and the Department for Science, Innovation and Technology (DSIT) has been designed to look at how obese patients can access weight management care more easily. This includes through community services, in pharmacies and online. Using these tools, eligible patients could be treated 'in a matter of months', according to Health Secretary Wes Streeting. Under the agreement, the Government will contribute up to £50 million in UK-wide investment. Meanwhile, Eli Lilly will back the programme with £35 million, and NHS organisations will be able to apply for a share of the funding. Recommended reading: Mounjaro warning as pens ruined by heatwave temperatures This comes as users are risking having to throw away perfectly good Mounjaro pens as they have overheated in the recent heatwave. Improper storage of Ozempic, Wegovy and Mounjaro during a heatwave could destroy the active ingredient in these jabs, potentially wiping out their effects entirely, even if the medication looks completely normal. 'We recommend treating your weight-loss pen the same way you'd treat insulin or any critical medication,' says Danielle Brightman, Clinical Director at Numan. 'When in doubt, don't risk it. Speak to a healthcare professional and arrange a replacement.' 8 tips to protect Mounjaro and other weight-loss injections during hot weather Use a medical-grade cool bag. Transport your pen in a proper, insulated container designed for sensitive medications. Don't use improvised ice packs that might freeze the pen by accident. Never leave your pen in hot places. Even 10 minutes in a parked car or on a sunny kitchen counter could expose it to damaging heat if out of its delivery packaging or unrefrigerated. Always check the environment before setting it down. Store below 30°C once in use. Once opened and if not refrigerated, keep your pen in a shaded, ventilated area, away from heat sources, windows, and radiators. If you live in a flat or home without air conditioning, keep the pen in a bedroom or hallway that doesn't heat up from direct sun. Avoid storing near exterior walls if the property retains heat. Follow the usage timeline carefully. The storage instructions between medications. Wegovy after first use can last 6 weeks below 30 degrees then needs to be disposed of, whereas Mounjaro has a shorter time of 30 days below 30 degrees before needing to be disposed of. Stick to that timeframe, and if you're unsure whether it's still safe, consult your provider. Use a fridge thermometer at home. Fridge temperatures can fluctuate, especially in older models or over-packed shelves. A simple digital fridge thermometer can help ensure your pen is always stored between 2–8°C before first use. Planning to travel? Use airline-friendly cooling cases. If you're flying or taking long journeys, consider TSA-approved insulated medication pouches with cooling gel packs. Always store the pen in carry-on luggage, not checked baggage, as cargo holds can get hot or cold. Set storage reminders on your phone. If you're prone to forgetting where you left your pen, set daily reminders to check if it's stored properly, especially during heatwaves or while travelling. Don't store near appliances or steam sources. Keep pens away from kettles, toasters, ovens, dishwashers, and anywhere that might experience sudden heat or humidity, especially in small kitchens or shared spaces. Injections like Ozempic, Wegovy, and Mounjaro are now widely used across the UK for appetite control and sustainable weight management. But despite their growing popularity and increasing availability now through the NHS, most patients don't realise the strict temperature guidelines that must be followed to keep these drugs effective. 'We speak to patients every day who are using GLP-1s for the first time,' says Danielle. 'With temperatures set to soar again this summer, it's crucial we raise awareness about safe medication storage. Heat damage isn't always obvious, but it can have a huge impact on effectiveness and safety."